Home
›
Monte Rosa Therapeutics, Inc.
› SCHEDULE 13D/A Nov 12, 2025
Monte Rosa Therapeutics, Inc. (GLUE): SCHEDULE 13D/A filed Nov 12, 2025
Form type
SCHEDULE 13D/A
Filing date
Nov 12, 2025
Accession number
0001193125-25-277603
Filer
Monte Rosa Therapeutics, Inc.
(CIK 1826457)